Welgene Biotech Co.,Ltd.

TPEX:6661 株式レポート

時価総額：NT$582.6m

Welgene BiotechLtd マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Yi Xing Lin

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権1.7%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Is Welgene Biotech Co.,Ltd.'s (GTSM:6661) 4.7% Dividend Sustainable?

Mar 19
Is Welgene Biotech Co.,Ltd.'s (GTSM:6661) 4.7% Dividend Sustainable?

Are Welgene BiotechLtd's (GTSM:6661) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 10
Are Welgene BiotechLtd's (GTSM:6661) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Welgene Biotech Co.,Ltd.'s (GTSM:6661) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 13
Welgene Biotech Co.,Ltd.'s (GTSM:6661) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Know This Before Buying Welgene Biotech Co.,Ltd. (GTSM:6661) For Its Dividend

Dec 10
Know This Before Buying Welgene Biotech Co.,Ltd. (GTSM:6661) For Its Dividend

CEO（最高経営責任者

Yi Xing Lin

no data

在職期間

Dr. Lin, Yi Xing serves as Director and General Manager at Welgene Biotech Co., Ltd.